CXSL2100110 | JS007注射液 | JS007 | Injection | Biological Products(1) | New Drug Application | 2021-04-01 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2021-03-31 | view |
CXSL2100083 | JS103注射液 | JS-103 | Injection | Biological Products(1) | New Drug Application | 2021-03-05 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2021-03-05 | view |
CXSL2100068 | JS201注射液 | JS-201 | Injection | Biological Products(1) | New Drug Application | 2021-02-24 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2021-02-23 | view |
CXSS2100016 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2021-02-11 | 上海君实生物医药科技股份有限公司,苏州众合生物医药科技有限公司 | Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd | Certificate Issued | 2021-12-01 | view |
CXSS2100018 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2021-02-11 | 上海君实生物医药科技股份有限公司,苏州众合生物医药科技有限公司 | Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd | Certificate Issued | 2021-12-01 | view |
CXSS2100017 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2021-02-11 | 上海君实生物医药科技股份有限公司,苏州众合生物医药科技有限公司 | Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd | Certificate Issued | 2021-12-01 | view |
CXSL2100027 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-22 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2021-01-21 | view |
CXSL2100026 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-22 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2021-01-21 | view |
CXSL2100028 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-22 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2021-01-21 | view |
CXSL2100009 | 重组人源化抗IL-17A单克隆抗体注射液 | recombinant humanized anti-IL17A monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-01-09 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2021-01-08 | view |
CXSL2000340 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2020-12-16 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2020-12-14 | view |
CXSL2000341 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2020-12-16 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2020-12-14 | view |
CXSL2000350 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2020-12-10 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2020-12-09 | view |
CXSL2000349 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2020-12-10 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2020-12-09 | view |
CXSL2000348 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2020-12-10 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2020-12-09 | view |
CXSL2000337 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2020-12-03 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2020-12-02 | view |
CXSL2000331 | JS006注射液 | JS006 | Injection | Biological Products(1) | New Drug Application | 2020-11-25 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2020-11-24 | view |
CXSL2000318 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2020-11-10 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2020-11-09 | view |
CXSL2000317 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2020-11-10 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2020-11-09 | view |
CXSL2000308 | 特瑞普利单抗注射液 | toripalimab | Injection | Biological Products(2.2) | New Drug Application | 2020-10-29 | 上海君实生物医药科技股份有限公司 | Shanghai Junshi Biosciences Co Ltd | In Review | 2020-10-28 | view |